Skip to main
IDXX

IDEXX Laboratories (IDXX) Stock Forecast & Price Target

IDEXX Laboratories (IDXX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 44%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

IDEXX Laboratories is well-positioned in the animal health market with its diverse and synergistic product portfolio, including reference lab services, point-of-care diagnostic tests, and software services for animal hospitals. With a growing global pet population and increasing focus on pet healthcare, IDEXX has a strong opportunity for growth in the long-term. Its financial stability and consistent revenue and earnings growth make it an attractive investment option.

Bears say

IDEXX Laboratories is a strong and established player in the animal diagnostics market with a focus on veterinary diagnostics and services. However, the company may face challenges in the near future, including lower pet visits due to economic factors, potential supply chain disruptions, and increased competition from other major players in the market such as ZTS. Additionally, IDEXX's stock is currently trading at a premium multiple, which may limit potential upside for investors. Despite strong financial performance, the company's outlook may be impacted by these factors, leading to a negative outlook.

IDEXX Laboratories (IDXX) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 44% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEXX Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEXX Laboratories (IDXX) Forecast

Analysts have given IDEXX Laboratories (IDXX) a Buy based on their latest research and market trends.

According to 9 analysts, IDEXX Laboratories (IDXX) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $721.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $721.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEXX Laboratories (IDXX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.